Atlas Trials

Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors

Clinical trial NCT00659126 · TERMINATED

Trial details

NCT number
NCT00659126
Sponsor
OHSU Knight Cancer Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Malignant Neoplasm in the BrainPrimary Brain Neoplasm
Start date
2006-11-16
Primary completion
2019-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.